Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
Botulinum neurotoxins (BoNTs) can be used therapeutically to treat a wide range of neuromuscular and neurological conditions. A collection of natural BoNT variants exists which can be classified into serologically distinct serotypes (BoNT/B), and further divided into subtypes (BoNT/B1, B2, …). BoNT...
Main Authors: | Jonathan R. Davies, Geoffrey Masuyer, Pål Stenmark |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/9/603 |
Similar Items
-
Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
by: Sara Košenina, et al.
Published: (2021-12-01) -
Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01) -
Botulinum neurotoxin X lacks potency in mice and in human neurons
by: Brieana M. Gregg, et al.
Published: (2024-03-01) -
Therapeutic Applications of Botulinum Neurotoxins in Veterinary Medicine
by: Lauretta Turin, et al.
Published: (2023-07-01) -
Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
by: Sylvia Valdezate, et al.
Published: (2023-10-01)